Open‐label, randomized, comparative, phase III study on effects of reducing steroid use in combination with Palonosetron

Publisher: John Wiley & Sons Inc

E-ISSN: 1349-7006|106|7|891-895

ISSN: 1347-9032

Source: Cancer Science, Vol.106, Iss.7, 2015-07, pp. : 891-895

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract